VDRM Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: October 30, 2024
Report Source: 2024 3rd Quarter Report
Viaderma Inc. Stock Analysis VDRM
ViaDerma, Inc. manufactures and sells pharmaceutical related products. The company is headquartered in Las Vegas, Nevada. The company went IPO on 2008-06-10. The firm is engaged in the manufacture and sale of pharmaceutical related products in the United States of America. The Company’s lead product is a topical antibiotic, which is focused on being sold under the brand name Vitastem. The firm also has products in development in the fields: anti-aging skin care, pain management, hair-loss, and toenail fungus. Its products are based on a patent-pending delivery system technology that allows for rapid mass transfer of the pharmaceutical active ingredient across the skin and into the body to provide immediate localized therapy. The firm utilizes a specific trade secret formulation system in the manufacture of all products. The Company’s products are sold to local medical practitioners and patients in clinics primarily in the Los Angeles, California area. The Company’s subsidiary is ViaDerma, II Inc.
Read More Viaderma Inc (VDRM) Chart
Key Statistics of Viaderma Inc (VDRM)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.00Volume
1.13MP/E Ratio (TTM)
-52 Week Range
Market Cap
493.49KAvg. Volume
114.01KDividend Yield
-Financial Metrics & Statements of Viaderma Inc (VDRM)
FAQ's for Viaderma Inc (VDRM)
- According to Musaffa’s Shariah screening methodology, Viaderma Inc (VDRM) is currently classified as NOT HALAL as of October 2024. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.